Neurodevelopmental Outcomes after Premedication with Atropine/Propofol vs Atropine/Atracurium/Sufentanil for Neonatal Intubation: 2-Year Follow-Up of a Randomized Clinical Trial - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The Journal of Pediatrics Année : 2021

Neurodevelopmental Outcomes after Premedication with Atropine/Propofol vs Atropine/Atracurium/Sufentanil for Neonatal Intubation: 2-Year Follow-Up of a Randomized Clinical Trial

(1, 2) , (3) , (4) , (5, 6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) ,
1
2
3
4
5
6
7
8
9
10
11
12
13

Résumé

This study followed 173 newborn infants in the PREmedication Trial for Tracheal Intubation of the NEOnate multicenter, double-blind, randomized controlled trial of atropine-propofol vs atropine-atracurium-sufentanil for premedication before nonemergency intubation. At 2 years of corrected age, there was no significant difference between the groups in death or risk of neurodevelopmental delay assessed with the Ages and Stages Questionnaire.
Fichier non déposé

Dates et versions

hal-03548014 , version 1 (29-01-2022)

Identifiants

Citer

Manon Tauzin, Laetitia Marchand-Martin, Cecile Lebeaux, Sophie Breinig, Olivier Claris, et al.. Neurodevelopmental Outcomes after Premedication with Atropine/Propofol vs Atropine/Atracurium/Sufentanil for Neonatal Intubation: 2-Year Follow-Up of a Randomized Clinical Trial. The Journal of Pediatrics, 2021, 231, pp.273+. ⟨10.1016/j.jpeds.2020.12.001⟩. ⟨hal-03548014⟩
39 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More